common.study.topics.clinical

Nicotine Content Cigarettes in a Complex Marketplace

common.study.values.description

Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace

This project will examine the impact of very low nicotine content (VLNC) cigarettes in a complex tobacco and nicotine product marketplace. We will compare the number of cigarettes smoked and cigarette-free days in an experimental marketplace that contains VLNC cigarettes versus normal nicotine content (NNC) cigarettes.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - Very Low Nicotine Content Cigarettes

0.4 mg/g nicotine; 9 mg tar

Drug - Normal Nicotine Content Cigarettes

15.8 mg/g nicotine; 9 mg tar

participant.views.study.view.additional

participant.views.study.view.scientific-title

Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace Part of "Evaluating New Nicotine Standards for Cigarettes"

common.study.values.clinical-trial-id

NCT03272685

participant.views.study.view.id

1aKqrd